The role of antiplatelet therapy in acute coronary syndromes and for secondary prevention following a myocardial infarction
- 31 August 1993
- journal article
- review article
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 36 (1) , 75-83
- https://doi.org/10.1016/0033-0620(93)90023-7
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Oral anticoagulation for secondary prevention after myocardial infarction with special reference to the warfarin re-infarction studyProgress in Cardiovascular Diseases, 1992
- Paradoxic elevation of fibrinopeptide A after streptokinase: Evidence for continued thrombosis despite intense fibrinolysisJournal of the American College of Cardiology, 1987
- Role of platelet activation and fibrin formation in thrombogenesisJournal of the American College of Cardiology, 1986
- Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina.Heart, 1985
- Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries.Circulation, 1984
- A Randomized, Controlled Trial of Aspirin in Persons Recovered From Myocardial InfarctionJAMA, 1980
- ASPIRIN AND SECONDARY MORTALITY AFTER MYOCARDIAL INFARCTIONThe Lancet, 1979
- Aspirin in coronary heart diseaseJournal of Chronic Diseases, 1976
- Platelet aggregation in partially obstructed vessels and its elimination with aspirin.Circulation, 1976
- A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial InfarctionBMJ, 1974